SecBot SecBot
8-K ·Filed Aug 12, 2026

TECH

BIO-TECHNE Corp
BULLISH
Impact 7/10
Horizonweeks Processed3mo ago SEC0001104659-26-094391
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The stock will trade at or near the $73 cash acquisition price until deal close, with the primary risk being regulatory or shareholder approval delays. The earnings release is largely a procedural update, the acquisition terms dominate the investment thesis. Monitor for regulatory clearance milestones and any competing bids.

DirectionBullish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

Executive Summary

Bio-Techne reported Q4 FY2026 results with organic revenue growth of 3% (reported +1% to $321.2M), GAAP EPS of $0.35 vs $(0.11) a year ago, and adjusted EPS of $0.52 vs $0.53 a year ago. The company also declared a $0.08/share quarterly dividend. However, the primary event is the previously announced agreement to be acquired by Merck KGaA for $73/share in cash (~$11.3B enterprise value), making this earnings release largely procedural as the company is no longer holding investor conference calls for quarterly results. The acquisition premium and deal certainty dominate the stock's trajectory, rendering the modest adjusted EPS decline and flat full-year revenue as secondary considerations.

Key Financial Metrics

EPS
$0.52
est $0.52 · 0.0%
Revenue
$321.2M
est $314.5M · +2.1% · +1.3% YoY
Rating
in line
Free Cash Flow
$263.2M
Gross Margin
65.8%

Key Facts

  • Bio-Techne entered into an agreement to be acquired by Merck KGaA, Darmstadt, Germany for $73 per share in cash, representing a total enterprise value of approximately $11.3 billion.
  • Q4 FY2026 organic revenue increased 3% (reported +1% to $321.2M); full-year revenue flat at $1.2 billion.
  • Q4 GAAP EPS was $0.35 vs $(0.11) a year ago; adjusted EPS was $0.52 vs $0.53 a year ago.
  • Full-year GAAP EPS was $1.16 vs $0.46; full-year adjusted EPS was $1.93 vs $1.92.
  • Bio-Techne declared a quarterly dividend of $0.08 per share, payable September 4, 2026.
  • In light of the announced transaction, Bio-Techne is no longer holding investor conference calls for quarterly results.

Financial Impact

Acquisition at $73/share represents a premium to the pre-announcement stock price, with total enterprise value of ~$11.3B. Q4 revenue of $321.2M and adjusted EPS of $0.52 are in line with expectations.

revenueepsenterprise value

Risk Factors

  • Regulatory or antitrust delays in closing the Merck KGaA acquisition
  • Shareholder vote failure or emergence of a competing bid at a lower price
  • Material adverse change or termination of the merger agreement

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
41% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-094391
Document: tech-20260812x8k.htm0001104659-26-094391
Document: tech-20260812xex99d2.htm0001104659-26-094391
Document: 0001104659-26-094391-index-headers.html0001104659-26-094391
Document: 0001104659-26-094391-index.html0001104659-26-094391
Document: 0001104659-26-094391.txt0001104659-26-094391
8-K Data (Synthetic)0001104659-26-094391

Track record

12 reports on TECH

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +2.07% at T+60 after the Jun 25, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 12, 20264d ago 10-Q/A Neutral 1/10 Entry $72.80 Now $72.79 −0.01% settles Dec 14
  2. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $72.66 Now $72.79 +0.18% settles Dec 4
  3. Nov 3, 202612d ago 8-K Neutral 2/10 Entry $72.73 Now $72.79 +0.08% settles Dec 3
  4. Nov 3, 202612d ago Press Release Neutral 2/10 Entry $72.73 Now $72.79 +0.08% settles Dec 3
  5. Oct 29, 202618d ago Institutional Cluster Bearish 4/10 Entry $72.71 Now $72.79 −0.11% settles Nov 27
  6. Oct 28, 202619d ago 10-K/A Neutral 3/10 Entry $72.71 Now $72.79 +0.11% settles Nov 27
  7. Sep 23, 20267w ago 8-K Bullish 6/10 Entry $72.57 to $72.62 Now $72.79 +0.30% ▲ +0.07% +0.49% vs SPY
  8. Sep 23, 20267w ago Press Release Bullish 6/10 Entry $72.52 to $72.64 Now $72.79 +0.37% ▲ +0.17% −0.52% vs SPY
  9. Aug 12, 202613w ago 8-K Bullish 7/10 Viewing No price data
  10. Aug 12, 202613w ago Press Release Neutral 4/10 Entry $72.23 to $72.08 Now $72.79 +0.78% ▼ −0.21% +1.69% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 12, 2026